By
Drug Target Review2024-06-27T12:00:59
The hiPSC-derived skeletal muscle model is the first to uncover the biological mechanisms underlying loss of mobility.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-07-11T16:13:06
Sponsored by Agilent
2024-02-08T11:07:39
Sponsored by Samplix ApS
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-01-16T10:21:42
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
Site powered by Webvision Cloud